270
Participants
Start Date
July 16, 2008
Primary Completion Date
April 9, 2009
Study Completion Date
April 9, 2009
SUN13834
Low dose, orally 3 times a day (tid) for 28 days of SUN13834
Placebo
Placebo, orally (tid) for 28 days of SUN13834
Derm Research Center of New York, Inc., Stony Brook
Paddington Testing Co, Inc., Philadelphia
Commonwealth Clinical Research Specialists, Inc., Richmond
Wake Forest University Health Sciences - Dermatology Studies, Winston-Salem
Wake Research Associates, LLC, Raleigh
Radiant Research, Inc, Greer
Advanced Dermatology and Cosmetic Surgery, Ormond Beach
Miami Research Associates, Miami
Stedman Clinical Trials, Tampa
Radiant Research, Inc., Birmingham
DermResearch, PLLC, Louisville
Toledo Center for Clinical Research, Sylvania
Deaconess Clinic Downtown Research Institute, Evansville
Michigan Center for Skin Care Research, Clinton Township
Burke Pharmaceutical Research, Hot Springs
Oklahoma University Health Sciences Center, Dermatology Dept, Oklahoma City
Baylor Research Institute of Dermatology Department, Dallas
J & S Studies, Inc, College Station
Dermatology Associates of San Antonio, San Antonio
Horizons Clinical Research Center, LLC, Denver
Northwest Clinical Trials, Boise
Intermountain Clinical Research, Draper
Pivotal Research Center, Mesa
Pivotal Research Center, Peoria
Academic Dermatology, Albuquerque
Therapeutics Clinical Research, San Diego
Premier Clinical Research, Spokane
Clinical Partners, LLC, Johnston
Lead Sponsor
Daiichi Sankyo
INDUSTRY